These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1638 related articles for article (PubMed ID: 18845344)

  • 1. Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up.
    Mazza M; Mandelli L; Di Nicola M; Harnic D; Catalano V; Tedeschi D; Martinotti G; Colombo R; Bria P; Serretti A; Janiri L
    J Affect Disord; 2009 May; 115(1-2):27-35. PubMed ID: 18845344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of switching from mania to depression in a large observational study across Europe (EMBLEM).
    Vieta E; Angst J; Reed C; Bertsch J; Haro JM;
    J Affect Disord; 2009 Nov; 118(1-3):118-23. PubMed ID: 19269690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders.
    Lee JH; Dunner DL
    Depress Anxiety; 2008; 25(2):91-7. PubMed ID: 17311265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bipolar obsessive-compulsive disorder: confirmation of results of the "ABC-OCD" survey in 2 populations of patient members versus non-members of an association].
    Hantouche EG; Kochman F; Demonfaucon C; Barrot I; Millet B; Lancrenon S; Akiskal HS
    Encephale; 2002; 28(1):21-8. PubMed ID: 11963340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline characteristics and outcomes in patients with first episode or multiple episodes of acute mania.
    Tohen M; Vieta E; Gonzalez-Pinto A; Reed C; Lin D;
    J Clin Psychiatry; 2010 Mar; 71(3):255-61. PubMed ID: 19709503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mania in the Nordic countries: patients and treatment in the acute phase of the EMBLEM study.
    Larsen JK; Porsdal V; Aarre TF; Koponen HJ; Aarnio J; Kleivenes OK;
    Nord J Psychiatry; 2009; 63(4):285-91. PubMed ID: 19140076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residual symptoms in bipolar disorder: the effect of the last episode after remission.
    Kaya E; Aydemir O; Selcuki D
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1387-92. PubMed ID: 17628288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subjective life satisfaction and objective functional outcome in bipolar and unipolar mood disorders: a longitudinal analysis.
    Goldberg JF; Harrow M
    J Affect Disord; 2005 Dec; 89(1-3):79-89. PubMed ID: 16249035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bipolar disorders and quality of life: the impact of attention deficit/hyperactivity disorder and substance abuse in euthymic patients.
    Sentissi O; Navarro JC; De Oliveira H; Gourion D; Bourdel MC; Baylé FJ; Olié JP; Poirier MF
    Psychiatry Res; 2008 Oct; 161(1):36-42. PubMed ID: 18786727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to ECT in bipolar I, bipolar II and unipolar depression.
    Medda P; Perugi G; Zanello S; Ciuffa M; Cassano GB
    J Affect Disord; 2009 Nov; 118(1-3):55-9. PubMed ID: 19223079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of moderate and excessive alcohol use on the course and outcome of patients with bipolar disorders: a prospective cohort study.
    van Zaane J; van den Brink W; Draisma S; Smit JH; Nolen WA
    J Clin Psychiatry; 2010 Jul; 71(7):885-93. PubMed ID: 20122372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic mania revisited: factors associated with treatment non-response during prospective follow-up of a large European cohort (EMBLEM).
    Van Riel WG; Vieta E; Martinez-Aran A; Haro JM; Bertsch J; Reed C; Van Os J
    World J Biol Psychiatry; 2008; 9(4):313-20. PubMed ID: 18949649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of co-occurring substance use on 6 month outcomes for young people seeking mental health treatment.
    Baker KD; Lubman DI; Cosgrave EM; Killackey EJ; Yuen HP; Hides L; Baksheev GN; Buckby JA; Yung AR
    Aust N Z J Psychiatry; 2007 Nov; 41(11):896-902. PubMed ID: 17924242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term stability of cognitive impairment in bipolar disorder: a 2-year follow-up study of lithium-treated euthymic bipolar patients.
    Mur M; Portella MJ; Martínez-Arán A; Pifarré J; Vieta E
    J Clin Psychiatry; 2008 May; 69(5):712-9. PubMed ID: 18435565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residual symptom recovery from major affective episodes in bipolar disorders and rapid episode relapse/recurrence.
    Judd LL; Schettler PJ; Akiskal HS; Coryell W; Leon AC; Maser JD; Solomon DA
    Arch Gen Psychiatry; 2008 Apr; 65(4):386-94. PubMed ID: 18391127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclothymic temperament as a prospective predictor of bipolarity and suicidality in children and adolescents with major depressive disorder.
    Kochman FJ; Hantouche EG; Ferrari P; Lancrenon S; Bayart D; Akiskal HS
    J Affect Disord; 2005 Mar; 85(1-2):181-9. PubMed ID: 15780688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of co-morbid substance use disorder in bipolar patients worsens their social functioning to the level observed in patients with schizophrenia.
    Jaworski F; Dubertret C; Adès J; Gorwood P
    Psychiatry Res; 2011 Jan; 185(1-2):129-34. PubMed ID: 20587365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The spectrum of substance abuse in bipolar disorder: reasons for use, sensation seeking and substance sensitivity.
    Bizzarri JV; Sbrana A; Rucci P; Ravani L; Massei GJ; Gonnelli C; Spagnolli S; Doria MR; Raimondi F; Endicott J; Dell'Osso L; Cassano GB
    Bipolar Disord; 2007 May; 9(3):213-20. PubMed ID: 17430295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why do clinicians maintain antidepressants in some patients with acute mania? Hints from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM), a large naturalistic study.
    Rosa AR; Cruz N; Franco C; Haro JM; Bertsch J; Reed C; Aarre TF; Sanchez-Moreno J; Vieta E
    J Clin Psychiatry; 2010 Aug; 71(8):1000-6. PubMed ID: 20361912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bipolar II and anxious reactive "comorbidity": toward better phenotypic characterization suitable for genotyping.
    Akiskal HS; Akiskal KK; Perugi G; Toni C; Ruffolo G; Tusini G
    J Affect Disord; 2006 Dec; 96(3):239-47. PubMed ID: 16973219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 82.